PMID- 20738320 OWN - NLM STAT- MEDLINE DCOM- 20110524 LR - 20131121 IS - 1365-2230 (Electronic) IS - 0307-6938 (Linking) VI - 36 IP - 3 DP - 2011 Apr TI - Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole. PG - 281-3 LID - 10.1111/j.1365-2230.2010.03926.x [doi] AB - Subacute cutaneous lupus erythematosus (SCLE) is characterized by annular scaly erythematous plaques in a photosensitive distribution, and the presence of anti-Ro (SSA) and/or anti-La (SSB) antibodies. Most cases of SCLE are idiopathic, but occasional cases may be drug-induced or associated with a hereditary deficiency of complement components. We report two cases of drug-induced SCLE precipitated by the proton pump inhibitor, omeprazole. Drug-induced disease should be considered in all atypical or extensive cases of SCLE, especially in elderly patients. CI - (c) The Author(s). CED (c) 2010 British Association of Dermatologists. FAU - Toms-Whittle, L M AU - Toms-Whittle LM AD - Department of Dermatology, Great Western Hospital NHS Foundation Trust, Swindon, Wiltshire, UK. FAU - John, L H AU - John LH FAU - Buckley, D A AU - Buckley DA LA - eng PT - Case Reports PT - Journal Article DEP - 20100825 PL - England TA - Clin Exp Dermatol JT - Clinical and experimental dermatology JID - 7606847 RN - 0 (Anti-Ulcer Agents) RN - 0 (Proton Pump Inhibitors) RN - KG60484QX9 (Omeprazole) SB - IM MH - Aged MH - Aged, 80 and over MH - Anti-Ulcer Agents/*adverse effects MH - Drug Eruptions/*etiology/pathology MH - Female MH - Humans MH - Lupus Erythematosus, Cutaneous/*chemically induced/pathology MH - Omeprazole/*adverse effects MH - Proton Pump Inhibitors/adverse effects EDAT- 2010/08/27 06:00 MHDA- 2011/05/25 06:00 CRDT- 2010/08/27 06:00 PHST- 2010/08/27 06:00 [entrez] PHST- 2010/08/27 06:00 [pubmed] PHST- 2011/05/25 06:00 [medline] AID - CED3926 [pii] AID - 10.1111/j.1365-2230.2010.03926.x [doi] PST - ppublish SO - Clin Exp Dermatol. 2011 Apr;36(3):281-3. doi: 10.1111/j.1365-2230.2010.03926.x. Epub 2010 Aug 25.